abstract |
There is provided a compound that selectively modulates the sphingosine 1 phosphate receptor, comprising a compound that modulates subtype 1 of the S1P receptor. The use, the method of treatment or prevention of the composition of the present invention, including the compounds of the present invention, and the method of manufacture are useful for the treatment or prevention of medically recommended diseases, conditions, and disorders in which the modulation of the sphingosine 1 phosphate receptor is medically recommended to provide. |